(Q34282867)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

Corrigendum to “Depression and epilepsy: Epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence” [Epilepsy Behav 24/2 (2012) 156–168]

2 February 2020

corrigendum / erratum

1 reference

10.1016/J.YEBEH.2013.12.017

DOI

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1016/J.YEBEH.2013.12.017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Michael Trimble

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Frank Gilliam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Rochelle Caplan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Alan E Ettinger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Andres M Kanner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Steven C Schachter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

John J Barry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Dale C Hesdorffer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Bruce Hermann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

David Dunn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

W Curt LaFrance

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

156-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22632406%20AND%20SRC:MED&resulttype=core&format=json

Phenomenology of depression in epilepsy

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The treatment of depression in patients with epilepsy. A double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depressive Illness in Patients with Epilepsy: A Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Psychiatric comorbidity, health, and function in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Predictors of pharmacoresistant epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Vigabatrin and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression and suicide attempt as risk factors for incident unprovoked seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression in epilepsy. Significance and phenomenology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression and epilepsy: a new perspective on two closely related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression and comorbidity in community-based patients with epilepsy or asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Amygdala enlargement in dysthymia--a volumetric study of patients with temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Major depression is a risk factor for seizures in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Co-occurrence of major depression or suicide attempt with migraine with aura and risk for unprovoked seizure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

An incident case-referent study of epileptic seizures in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Symptoms of depression and anxiety in pediatric epilepsy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Presentation and course of major depressive disorder during childhood and later years of the life span

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The family history method using diagnostic criteria. Reliability and validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Psychodynamics and psychiatric diagnoses of pseudoseizure subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

An estimate of the prevalence of psychogenic non-epileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Incidence of psychogenic seizures in adults: a population-based study in Iceland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Psychogenic nonepileptic seizures: diagnosis and initial management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Acute Unstable Depressive Syndrome (AUDS) is associated more frequently with epilepsy than major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression and risk for onset of type II diabetes. A prospective population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression: a major, unrecognized risk factor for osteoporosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Increased risk of Parkinson's disease after depression: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Symptoms of depression as a prospective risk factor for stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Psychiatric illness following traumatic brain injury in an adult health maintenance organization population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Placebo response in studies of major depression: variable, substantial, and growing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Migraine with aura is a risk factor for unprovoked seizures in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The impact of migraine on epilepsy: a prospective prognosis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression and epilepsy: a review of multiple facets of their close relation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Anxiolytic effects of rapid amygdala kindling, and the influence of early life experience in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Early postnatal stress confers enduring vulnerability to limbic epileptogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Postnatal epigenetic influences on seizure susceptibility in seizure-prone versus seizure-resistant rat strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Low glial numbers in the amygdala in major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Glial cell abnormalities in major psychiatric disorders: the evidence and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Glial reduction in the subgenual prefrontal cortex in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Beyond monoamines: glutamatergic function in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Fluoxetine increases GABA(A) receptor activity through a novel modulatory site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

GABAergic dysfunction in mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The role of cytokines in the pathophysiology of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Cytokines as mediators of depression: what can we learn from animal studies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Noradrenergic abnormalities in the genetically epilepsy-prone rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Drug dependence potential of viloxazine hydrochloride tested in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Effects of several centrally active drugs on the sleep-wakefulness cycle of cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Fluoxetine inhibition of glycine receptor activity in rat hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Cerebral metabolism and depression in patients with complex partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Prefrontal cortical networks related to visceral function and mood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression in temporal lobe epilepsy surgery patients: an FDG-PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Temporal lobe epilepsy, depression, and hippocampal volume

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Relation of interictal spike frequency to 1H-MRSI-measured NAA/Cr.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Metabolic and electrophysiological alterations in subtypes of temporal lobe epilepsy: a combined proton magnetic resonance spectroscopic imaging and depth electrodes study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Emotion, plasticity, context, and regulation: perspectives from affective neuroscience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The neurobiology of cognitive disorders in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Cortical thickness analysis in temporal lobe epilepsy: reproducibility and relation to outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Neuroanatomical correlates of cognitive phenotypes in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The neural bases of distraction and reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

inferred from DOI database lookup

7 January 2021

based on heuristic

A functional anatomical study of unipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Positron emission tomography imaging in depression: a neural systems perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Effect of sertraline on regional metabolic rate in patients with affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

A meta-analytic study of changes in brain activation in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Lower serotonin transporter binding potential in the human brain during major depressive episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

PET imaging of serotonin 1A receptor binding in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Serotonin type-1A receptor imaging in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Serotonin-1A receptor imaging in recurrent depression: replication and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Effect of electroconvulsive therapy on 5-HT1A receptor binding in patients with depression: a PET study with [11C]WAY 100635.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

5-HT(1A) receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: a pilot [¹⁸F]MPPF positron emission tomography study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Research letter: Psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-(11)C]WAY-100635 PET study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Psychiatric outcome after temporal lobectomy: a predictive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Brain metabolic alterations in medication-free patients with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Antidepressant effects of ketamine in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

An open-label trial of riluzole in patients with treatment-resistant major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Reduced volume of orbitofrontal cortex in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Decreased hippocampal volume in healthy girls at risk of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Antiepileptic drug response in temporal lobe epilepsy: A clinical and MRI morphometry study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007

Anticonvulsant drugs and mental symptoms: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.01.007